Dr. Maloney Discusses Excitement With CAR T-Cell Therapy
David G. Maloney, MD, PhD, member of the Clinical Research Division, Fred Hutchinson Cancer Research Center, Washington, discusses excitement with CAR T-cell therapy.
David G. Maloney, MD, PhD, member of the Clinical Research Division, Fred Hutchinson Cancer Research Center, Washington, discusses excitement with chimeric antigen receptor (CAR) T-cell therapy.
With the recent FDA approval of tisagenlecleucel (Kymriah) in acute lymphocytic leukemia (ALL), there has been a lot of buzz about CAR T cell-therapy in hematologic malignancies.
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Recent Videos
Related Content
